相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of Survivin Restores the Sensitivity of Breast Cancer Cells to Docetaxel and Vinblastine
Parisa Ghanbari et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2014)
HER2 stabilizes survivin while concomitantly down-regulating survivin gene transcription by suppressing Notch cleavage
Ji-hyun Ju et al.
BIOCHEMICAL JOURNAL (2013)
Survivin - biology and potential as a therapeutic target in oncology
Chun Hei Antonio Cheung et al.
ONCOTARGETS AND THERAPY (2013)
Neoadjuvant chemotherapy in ER+HER2-breast cancer: response prediction based on immunohistochemical and molecular characteristics
E. H. Lips et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies
S. Murray et al.
CANCER TREATMENT REVIEWS (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
Christos Hatzis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Jing Lu et al.
CLINICAL CANCER RESEARCH (2009)
Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer
Fiona M. Foster et al.
BREAST CANCER RESEARCH (2009)
Increased survivin expression confers chemoresistance to tumor-associated endothelial cells
Jenilyn J. Virrey et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Upregulation of survivin by leptin/STAT3 signaling in MCF-7 cells
Haiping Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways
Aisha Siddiqa et al.
BMC CANCER (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Regulation of mitochondrial Smac/DIABLO-selective release by survivin
G. Ceballos-Cancino et al.
ONCOGENE (2007)
The inhibitor of apoptosis proteins as therapeutic targets in cancer
Domagoj Vucic et al.
CLINICAL CANCER RESEARCH (2007)
Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death
Meihua Sui et al.
CANCER RESEARCH (2007)
Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients
A. R. Hinnis et al.
BRITISH JOURNAL OF CANCER (2007)
Expression of survivin in renal cell carcinomas: Association with pathologic features and clinical outcome
Seok-Soo Byun et al.
UROLOGY (2007)
The inhibitors of apoptosis (IAPs) as cancer targets
Allison M. Hunter et al.
APOPTOSIS (2007)
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
Stephen E. Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The case for survivin as a regulator of microtubule dynamics and cell-death decisions
Dario C. Altieri
CURRENT OPINION IN CELL BIOLOGY (2006)
Regulation of survivin by ErbB2 signaling: Therapeutic implications for ErbB2-overexpressing breast cancers
WL Xia et al.
CANCER RESEARCH (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells
H Asanuma et al.
CANCER RESEARCH (2005)
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
A Papapetropoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
